Victor J. Dzau is President of the Institute of Medicine, Chancellor Emeritus at Duke University and former CEO of the Duke University Health System. Professor Dzau has made a significant impact through his seminal research in cardiovascular medicine and his leadership in health care innovation. He has led efforts in innovation to improve health, including developing the Duke Translational Medicine Institute, Duke Global Health Institute, Duke-National University of Singapore Graduate Medical School, and Duke Institute for Health Innovation. He has served on the Advisory Committee to the Director of National Institutes of Health (NIH) and chaired the NIH Cardiovascular Disease Advisory Committee. Currently he is a member of the Board of the Singapore Health System and Hamad Medical Corporation, Qatar. He chaired the Global Agenda Council on Personalized and Precision Medicine of the World Economic Forum. Among his many honors are the Gustav Nylin Medal from the Swedish Royal College of Medicine, Distinguished Scientist Award from American Heart Association and the Public Service Medal from the President of Singapore.